Targeting Copper Dysregulation In Cancer: Molecular Insights Into Cuproptosis and The Promise of Copper-Based Nanomedicine
DOI:
https://doi.org/10.63682/jns.v14i30S.6923Keywords:
Copper, Cuproptosis, Cancer therapy, Drug resistance, ApoptosisAbstract
Copper is an essential transition metal that plays a vital role in cellular metabolism as a cofactor for key enzymes. While necessary for biological processes such as mitochondrial respiration, antioxidant defense, and gene expression, copper must be tightly regulated to prevent cytotoxicity. This review investigates copper homeostasis at both cellular and systemic levels, highlighting the significance of dietary intake, absorption, transport, and excretion. Dysregulation of copper can lead to cell death, especially in cancer cells, through mechanisms such as cuproptosis, a newly recognized form of copper-induced cell death. Cuproptosis involves mitochondrial copper accumulation, disrupting protein function, and triggering cell death. The study explores how copper imbalance contributes to cancer progression, metastasis, drug resistance, and immune evasion. Therapeutic approaches targeting copper metabolism are discussed, including the use of copper chelators and copper-based nanomaterials to improve cancer treatment. Although cuproptosis has sometimes been misinterpreted as the result of ionophore-induced nanoparticle formation, it stems from mitochondrial copper toxicity. The review further evaluates the emerging role of copper nanotechnology in sensitizing tumors to chemotherapy, offering a promising strategy to overcome drug resistance. Overall, the findings underscore copper’s dual role in health and disease and its potential as a therapeutic target in oncology.
Downloads
Metrics
References
Ferlay, J. et al. Cancer statistics for the year 2020: An overview. International Journal of Cancer 149, 778–789 (2021).
Hanahan, D. & Weinberg, R. A. Hallmarks of Cancer: The Next Generation. Cell 144, 646–674 (2011).
Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death & Differentiation 25, 486–541 (2018).
Christgen, S., Tweedell, R. E. & Kanneganti, T.-D. Programming inflammatory cell death for therapy. Pharmacology & Therapeutics 232, 108010 (2022).
Lelièvre, P., Sancey, L., Coll, J.-L., Deniaud, A. & Busser, B. The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy. Cancers 12, 3594 (2020).
Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254–1261 (2022).
Eskici, G. & Axelsen, P. H. Copper and Oxidative Stress in the Pathogenesis of Alzheimer’s Disease. Biochemistry 51, 6289–6311 (2012).
Pavithra, V. Serum Levels of Metal Ions in Female Patients with Breast Cancer. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2015)
Xie, J., Yang, Y., Gao, Y. & He, J. Cuproptosis: mechanisms and links with cancers. Molecular Cancer 22, 46 (2023).
Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254–1261 (2022).
Festa, R. A. & Thiele, D. J. Copper: An essential metal in biology. Current Biology vol. 21 at https://doi.org/10.1016/j.cub.2011.09.040 (2011).
Wang, P. et al. Biological applications of copper-containing materials. Bioactive Materials 6, 916–927 (2021).
Nose, Y., Kim, B.-E. & Thiele, D. J. Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function. Cell Metabolism 4, 235–244 (2006).
Freedman, J. H., Ciriolo, M. R. & Peisach, J. The Role of Glutathione in Copper Metabolism and Toxicity. Journal of Biological Chemistry 264, 5598–5605 (1989).
Li, Y. Copper homeostasis: Emerging target for cancer treatment. IUBMB Life 72, 1900–1908 (2020).
Chen, L., Min, J. & Wang, F. Copper homeostasis and cuproptosis in health and disease. Signal Transduction and Targeted Therapy 7, 378 (2022).
Linder, M. C. Biochemistry of Copper. Springer Science & Business Media, Berlin, (2013).
Grubman, A. & White, A. R. Copper as a key regulator of cell signalling pathways. Expert Reviews in Molecular Medicine 16, e11 (2014).
Nývltová, E., Dietz, J. v., Seravalli, J., Khalimonchuk, O. & Barrientos, A. Coordination of metal center biogenesis in human cytochrome c oxidase. Nature Communications 13, 3615 (2022).
Storz, P. Reactive oxygen species in tumor progression. Frontiers in Bioscience vol. 10 1881–1896 at https://doi.org/10.2741/1667 (2005).
Nakamura, H. & Takada, K. Reactive oxygen species in cancer: Current findings and future directions. Cancer Science 112, 3945–3952 (2021).
Yoshii, J. et al. The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. International Journal of Cancer 94, 768–773 (2001).
Ge, E. J. et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nature Reviews Cancer 22, 102–113 (2022).
Solomon, E. I., Sundaram, U. M. & Machonkin, T. E. Multicopper Oxidases and Oxygenases. Chemical Reviews 96, 2563–2606 (1996).
Wang, X., Zhou, M., Liu, Y. & Si, Z. Cope with copper: From copper linked mechanisms to copper-based clinical cancer therapies. Cancer Letters 561, 216157 (2023).
Finney, L., Vogt, S., Fukai, T. & Glesne, D. COPPER AND ANGIOGENESIS: UNRAVELLING A RELATIONSHIP KEY TO CANCER PROGRESSION. Clinical and Experimental Pharmacology and Physiology 36, 88–94 (2009).
Ribatti, Domenico, et al. Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma. Oncology reports 14.1 (2005): 81-84.
Jiang, X. et al. The role of microenvironment in tumor angiogenesis. Journal of Experimental & Clinical Cancer Research 39, 204 (2020).
Gérard, C., Bordeleau, L.-J., Barralet, J. & Doillon, C. J. The stimulation of angiogenesis and collagen deposition by copper. Biomaterials 31, 824–831 (2010).
Li, Y. Copper homeostasis: Emerging target for cancer treatment. IUBMB Life 72, 1900–1908 (2020).
Juarez, J. C. et al. Copper Binding by Tetrathiomolybdate Attenuates Angiogenesis and Tumor Cell Proliferation through the Inhibition of Superoxide Dismutase 1. Clinical Cancer Research 12, 4974–4982 (2006).
Qiu, L., Ding, X., Zhang, Z. & Kang, Y. J. Copper Is Required for Cobalt-Induced Transcriptional Activity of Hypoxia-Inducible Factor-1. The Journal of Pharmacology and Experimental Therapeutics 342, 561–567 (2012).
Park, K. C. et al. Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics. Metallomics 8, 874–886 (2016).
Ungar-Waron, M., Gluckman, A., Spira, E., Waron, M. & Ev Trainin, Z. ’. Ceruloplasmin as a Marker of Neoplastic Activity in Rabbits Bearing the VX-2 Carcinoma1. CANCER RESEARCH vol. 38 http://aacrjournals.org/cancerres/article-pdf/38/5/1296/2401822/cr0380051296.pdf (1978).
Badet, J. et al. Specific binding of angiogenin to calf pulmonary artery endothelial cells. Proceedings of the National Academy of Sciences 86, 8427–8431 (1989).
Das, A. et al. Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis. Nature Cell Biology 24, 35–50 (2022).
C Reygaert, W. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiology 4, 482–501 (2018).
Longley, D. & Johnston, P. Molecular mechanisms of drug resistance. The Journal of Pathology 205, 275–292 (2005).
Majumder, S. et al. The role of copper in drug-resistant murine and human tumors. BioMetals 22, 377–384 (2009).
Jin, J. et al. Copper enhances genotoxic drug resistance via ATOX1 activated DNA damage repair. Cancer Letters 536, 215651 (2022).
Srinivasan, P., Wu, X., Basu, M., Rossi, C. & Sandler, A. D. PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease. PLOS Medicine 15, e1002497 (2018).
Voli, F. et al. Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion. Cancer Research 80, 4129–4144 (2020).
Zhou, B. et al. Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma. Am J Cancer Res vol. 9 www.ajcr.us/ (2019).
Voli, F. et al. Harnessing copper in cancer to enhance anti-tumor immune response. Annals of Oncology 29, x35 (2018).
Chaffer, C. L. & Weinberg, R. A. A Perspective on Cancer Cell Metastasis. Science 331, 1559–1564 (2011).
Cano, A. et al. The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression. Nature Cell Biology 2, 76–83 (2000).
Kamiya, T. Copper in the tumor microenvironment and tumor metastasis. Journal of Clinical Biochemistry and Nutrition 71, 22–9 (2022).
Laukkanen, M. O. Extracellular Superoxide Dismutase: Growth Promoter or Tumor Suppressor? Oxidative Medicine and Cellular Longevity vol. 2016 at https://doi.org/10.1155/2016/3612589 (2016).
Xiao, Q. & Ge, G. Lysyl Oxidase, Extracellular Matrix Remodeling and Cancer Metastasis. Cancer Microenvironment 5, 261–273 (2012).
Erler, J. T. et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440, 1222–1226 (2006).
Lapointe, J. et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proceedings of the National Academy of Sciences 101, 811–816 (2004).
MacDonald, G. et al. Memo Is a Copper-Dependent Redox Protein with an Essential Role in Migration and Metastasis. Science Signaling 7, (2014).
Johnston, K. A. & Lopez, K. M. Lysyl oxidase in cancer inhibition and metastasis. Cancer Letters 417, 174–181 (2018).
Tang, D., Chen, X. & Kroemer, G. Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Research 32, 417–418 (2022).
Li, S.-R., Bu, L.-L. & Cai, L. Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway. Signal Transduction and Targeted Therapy 7, 158 (2022).
Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254–1261 (2022).
Solmonson, A. & DeBerardinis, R. J. Lipoic acid metabolism and mitochondrial redox regulation. Journal of Biological Chemistry 293, 7522–7530 (2018).
Skrott, Z. et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature 552, 194–199 (2017).
Dreishpoon, M. B. et al. FDX1 regulates cellular protein lipoylation through direct binding to LIAS. at https://doi.org/10.1101/2023.02.03.526472 (2023).
Ge, E. J. et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nature Reviews Cancer 22, 102–113 (2022).
Zhang, X. et al. Copper-mediated novel cell death pathway in tumor cells and implications for innovative cancer therapies. Biomedicine & Pharmacotherapy 168, 115730 (2023).
Miller, K. D. et al. Cancer treatment and survivorship statistics, 2022. CA: A Cancer Journal for Clinicians 72, 409–436 (2022).
Ternet, C. & Kiel, C. Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage. Cell Communication and Signaling 19, 31 (2021).
Itoh, S. et al. Novel Role of Antioxidant-1 (Atox1) as a Copper-dependent Transcription Factor Involved in Cell Proliferation. Journal of Biological Chemistry 283, 9157–9167 (2008).
Samimi, G. et al. Increased Expression of the Copper Efflux Transporter ATP7A Mediates Resistance to Cisplatin, Carboplatin, and Oxaliplatin in Ovarian Cancer Cells. Clinical Cancer Research 10, 4661–4669 (2004).
Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians 71, 209–249 (2021).
Du, C. et al. Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc. Cancer Chemotherapy and Pharmacology 89, 451–458 (2022).
Lin, Y., Kikuchi, S., Obata, Y. & Yagyu, K. Serum Copper/Zinc Superoxide Dismutase (Cu/Zn SOD) and Gastric Cancer Risk: a Case‐Control Study. Japanese Journal of Cancer Research 93, 1071–1075 (2002)
Rumgay, H. et al. Global burden of primary liver cancer in 2020 and predictions to 2040. Journal of Hepatology 77, 1598–1606 (2022).
Konyn, P., Ahmed, A. & Kim, D. Current epidemiology in hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 15, 1295–1307 (2021).
Ebara, M. et al. Metal Contents in the Liver of Patients with Chronic Liver Disease Caused by Hepatitis C Virus. Oncology 65, 323–330 (2003).
Soreze, Y. et al. Mutations in human lipoyltransferase gene LIPT1cause a Leigh disease with secondary deficiency for pyruvate and alpha-ketoglutarate dehydrogenase. Orphanet Journal of Rare Diseases 8, 192 (2013).
Park, Y.-H. & Patel, M. S. Characterization of interactions of dihydrolipoamide dehydrogenase with its binding protein in the human pyruvate dehydrogenase complex. Biochemical and Biophysical Research Communications 395, 416–419 (2010).
Park, Y.-H. & Patel, M. S. Characterization of interactions of dihydrolipoamide dehydrogenase with its binding protein in the human pyruvate dehydrogenase complex. Biochemical and Biophysical Research Communications 395, 416–419 (2010).
Tsang, T. et al. Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma. Nature Cell Biology 22, 412–424 (2020).
Mayr, J. A. et al. Lipoic Acid Synthetase Deficiency Causes Neonatal-Onset Epilepsy, Defective Mitochondrial Energy Metabolism, and Glycine Elevation. The American Journal of Human Genetics 89, 792–797 (2011).
Houvenaeghel, G. et al. Lymph node positivity in different early breast carcinoma phenotypes: a predictive model. BMC Cancer 19, 45 (2019).
Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians 71, 209–249 (2021).
Blockhuys, S. & Wittung-Stafshede, P. Copper chaperone Atox1 plays role in breast cancer cell migration. Biochemical and Biophysical Research Communications 483, 301–304 (2017).
Agarwal, P., Sandey, M., DeInnocentes, P. & Bird, R. C. Tumor suppressor gene p16/INK4A/CDKN2A‐dependent regulation into and out of the cell cycle in a spontaneous canine model of breast cancer. Journal of Cellular Biochemistry 114, 1355–1363 (2013).
Leonardi, G. et al. Cutaneous melanoma: From pathogenesis to therapy (Review). International Journal of Oncology (2018) doi:10.3892/ijo.2018.4287.
Brady, D. C. et al. Copper is required for oncogenic BRAF signalling and tumorigenesis. Nature 509, 492–496 (2014).
Walboomers, J. M. M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology 189, 12–19 (1999).
Lei, L., Tan, L. & Sui, L. A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer. Frontiers in Genetics 13, (2022).
Johnson, D. E. et al. Head and neck squamous cell carcinoma. Nature Reviews Disease Primers 6, 92 (2020).
Zhang, S. et al. A cuproptosis and copper metabolism–related gene prognostic index for head and neck squamous cell carcinoma. Frontiers in Oncology 12, (2022).
Zhang, S. et al. A cuproptosis and copper metabolism–related gene prognostic index for head and neck squamous cell carcinoma. Frontiers in Oncology 12, (2022).
Xu, Y. et al. Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients. Journal of Oncology 2022, 1–15 (2022).
Tsang, T., Davis, C. I. & Brady, D. C. Copper biology. Current Biology 31, R421–R427 (2021).
Garza, N. M., Swaminathan, A. B., Maremanda, K. P., Zulkifli, M. & Gohil, V. M. Mitochondrial copper in human genetic disorders. Trends in Endocrinology & Metabolism 34, 21–33 (2023).
Gao, L. & Zhang, A. Copper-instigated modulatory cell mortality mechanisms and progress in oncological treatment investigations. Frontiers in Immunology vol. 14 at https://doi.org/10.3389/fimmu.2023.1236063 (2023).
Bost, M. et al. Dietary copper and human health: Current evidence and unresolved issues. Journal of Trace Elements in Medicine and Biology 35, 107–115 (2016).
Lönnerdal, B. Intestinal regulation of copper homeostasis: a developmental perspective. The American Journal of Clinical Nutrition 88, 846S-850S (2008).
Lutsenko, S. Dynamic and cell-specific transport networks for intracellular copper ions. Journal of Cell Science 134, (2021).
Sheline, C. T. & Choi, D. W. Cu 2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo. Annals of Neurology 55, 645–653 (2004).
Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254–1261 (2022).
Oliveri, V. Biomedical applications of copper ionophores. Coordination Chemistry Reviews 422, 213474 (2020).
Zheng, P., Zhou, C., Lu, L., Liu, B. & Ding, Y. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. Journal of Experimental & Clinical Cancer Research 41, 271 (2022).
Di, X., Pei, Z., Pei, Y. & James, T. D. Tumor microenvironment-oriented MOFs for chemodynamic therapy. Coordination Chemistry Reviews 484, 215098 (2023).
Pei, Z., Lei, H. & Cheng, L. Bioactive inorganic nanomaterials for cancer theranostics. Chemical Society Reviews 52, 2031–2081 (2023).
Ostrakhovitch, E. A., Lordnejad, M. R., Schliess, F., Sies, H. & Klotz, L.-O. Copper Ions Strongly Activate the Phosphoinositide-3-Kinase/Akt Pathway Independent of the Generation of Reactive Oxygen Species. Archives of Biochemistry and Biophysics 397, 232–239 (2002).
Baldari, S. et al. Effects of Copper Chelation on BRAFV600E Positive Colon Carcinoma Cells. Cancers 11, 659 (2019).
Tsang, T. et al. Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma. Nature Cell Biology 22, 412–424 (2020).
Onuma, T., Mizutani, T., Fujita, Y., Yamada, S. & Yoshida, Y. Copper content in ascitic fluid is associated with angiogenesis and progression in ovarian cancer. Journal of Trace Elements in Medicine and Biology 68, 126865 (2021).
Wu, Z., Zhang, W. & Kang, Y. J. Copper affects the binding of HIF-1α to the critical motifs of its target genes. Metallomics 11, 429–438 (2019).
Nusse, R. & Clevers, H. Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities. Cell vol. 169 985–999 at https://doi.org/10.1016/j.cell.2017.05.016 (2017).
Chen, G.-S. et al. Stabilization of the c-Myc Protein via the Modulation of Threonine 58 and Serine 62 Phosphorylation by the Disulfiram/Copper Complex in Oral Cancer Cells. International Journal of Molecular Sciences 23, 9137 (2022).
Du, C. et al. Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc. Cancer Chemotherapy and Pharmacology 89, 451–458 (2022).
Qu, Y. et al. Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells. Breast Cancer Research and Treatment 121, 311–321 (2010).
Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254–1261 (2022).
Chen, J. et al. CuS–NiS 2 nanomaterials for MRI guided phototherapy of gastric carcinoma via triggering mitochondria-mediated apoptosis and MLKL/CAPG-mediated necroptosis. Nanotoxicology 14, 774–787 (2020).
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
